Gencurix Inc

Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on a digital PCR platform; eDX, an early cancer diagnosis using liquid biopsy; the GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and the GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. to develop oncology assays for use on the QIAcuityDx platform. Gencurix was founded in 2011 and is headquartered in Seoul, South Korea.